Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study.

Infection · 2024 · PMC11289057 · PMID 38652224

Europe PMC DOI

hedged sentence

0.1290

closest p · 2.6× alpha

0.1290

boldest claim

The sentences

did not reach statistical significancep = 0.129not close (p > 0.1)

Furthermore, antibody levels were marginally associated with the risk of death/intubation, although the difference did not reach statistical significance ( p = 0.129).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.